Medication Use Evaluation of Dronedarone in Comparison to Amiodarone

Medication Use Evaluation of Dronedarone in Comparison to Amiodarone

Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Adam Corey, Nita Johnston
Materialtyp:	Artikel
Språk:	English
Publicerad:	University of Minnesota Libraries Publishing 2016-12-01
Serie:	INNOVATIONS in Pharmacy
Ämnen:	Dronedarone, Amiodarone, Medication Use Evaluation, Atrial Fibrillation
Länkar:	https://pubs.lib.umn.edu/index.php/innovations/article/view/480

Liknande verk

Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
av: Li Y, et al.
Publicerad: (2023-12-01)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
av: Mengran Zhang, et al.
Publicerad: (2021-08-01)

Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
av: Li-Qin Jiang, et al.
Publicerad: (2016-05-01)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
av: Trigo P, et al.
Publicerad: (2011-12-01)

Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
av: M. Yu. Gilyarov, et al.
Publicerad: (2010-12-01)

Dronedarone for the management of atrial fibrillation
av: Swiss Medical Weekly
Publicerad: (2011-02-01)

Comparative effects of amiodarone and dronedarone treatments on cardiac function in a rabbit model
av: Worakan Boonhoh, et al.
Publicerad: (2019-02-01)

Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS
av: Ye Xu, et al.
Publicerad: (2024-10-01)

Simultaneous determination of amiodarone, dronedarone, and their principal metabolites in SD rat plasma by UPLC-MS/MS and its application in pharmacokinetics
av: Ying Zhang, et al.
Publicerad: (2021-08-01)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
av: Christine Benn Christiansen, et al.
Publicerad: (2010-03-01)

THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS
av: O. V. Gaisenok
Publicerad: (2016-01-01)

Marked prolongation of QRS duration after initiation of dronedarone therapy
av: Conrad Genz, et al.
Publicerad: (2014-08-01)

Bioavailability of dronedarone tablets administered with or without food in healthy participants
av: Gerald V. Naccarelli, et al.
Publicerad: (2024-09-01)

Analysis of a Serious Adverse Reaction of Pulmonary Fibrosis Caused by Dronedarone
av: Yuyan Chen, PM, et al.
Publicerad: (2024-01-01)

Dronedarone for Recurrent Ventricular Tachycardia: A Real Alternative?
av: Victor Exposito, MD, et al.
Publicerad: (2012-03-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
av: A. G. Pronin, et al.
Publicerad: (2020-12-01)

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION
av: O. V. Gaisenok
Publicerad: (2016-01-01)

Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study
av: Hesham S. Taha, et al.
Publicerad: (2022-05-01)

Dronedarone-induced photoallergic reaction
av: Levy Amar, PhD, et al.
Publicerad: (2020-12-01)

Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
av: Niloofar Dadashpour, et al.
Publicerad: (2015-06-01)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
av: S. Yu. Martsevich, et al.
Publicerad: (2016-01-01)

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
av: Abolfath Alizadeh, et al.
Publicerad: (2022-01-01)

Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
av: K. G. Adamyan, et al.
Publicerad: (2015-11-01)

Amiodarone-Induced Pulmonary Toxicity in a Patient With Paroxysmal Atrial Fibrillation and Recurrence of Pulmonary Toxicity
av: Nuri Köse, et al.
Publicerad: (2022-01-01)

Amiodarone treatment investigation on the correlation between the drug sensitivity for paroxysmal atrial fibrillation and gene polymorphism
av: Shuxin Hou, et al.
Publicerad: (2016-01-01)

Does prophylactic low-dose amiodarone decrease the incidence of postoperative atrial fibrillation after coronary artery bypass graft surgery? A randomized controlled trial
av: Mohamed Ali Ahmed, et al.
Publicerad: (2022-09-01)

Transient Bradyarrhythmia A Sole Presentation of Amiodarone-Induced Hypothyroidism
av: Gautam Jesrani, et al.
Publicerad: (2021-04-01)

Amiodarone pulmonary toxicity: Case report
av: Vasić Nada, et al.
Publicerad: (2014-01-01)

Rhythm and rate control effects of intravenous amiodarone for atrial fibrillation complicated by acutely decompensated heart failure
av: Daisuke Horiuchi, MD, et al.
Publicerad: (2014-06-01)

SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE
av: N P Dorofeeva, et al.
Publicerad: (2017-03-01)

Late-onset thyrotoxicosis after the cessation of amiodarone
av: Melissa E. Middeldorp, et al.
Publicerad: (2020-11-01)

Evaluation of Amiodarone Administration in Patients with New-Onset Atrial Fibrillation in Septic Shock
av: Andreea Oprea, et al.
Publicerad: (2024-09-01)

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
av: D. A. Kuzhel, et al.
Publicerad: (2016-01-01)

Case Report: Amiodarone-induced multi-organ toxicity
av: Jingrui Yan, et al.
Publicerad: (2024-07-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
av: V. A. Sulimov, et al.
Publicerad: (2016-01-01)

Cardiomyocyte-Targeting Peptide to Deliver Amiodarone
av: Maliha Zahid, et al.
Publicerad: (2023-08-01)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
av: Kuan-Cheng Lai, et al.
Publicerad: (2018-05-01)

A case of probable Amiodarone-induced pancreatitis in the treatment of atrial fibrillation: a literature review and case report
av: Christopher J. Mercogliano, et al.
Publicerad: (2017-11-01)

The incidence of phlebitis development of high concentration of continuous amiodarone infusion with in-line filter compared to the low concentration without in-line filter: a retrospective propensity score-matched analysis
av: Sirichai Cheewatanakornkul, et al.
Publicerad: (2022-08-01)

Local Use of Hydrogel with Amiodarone in Cardiac Surgery: Experiment and Translation to the Clinic
av: Vladimir Shvartz, et al.
Publicerad: (2021-03-01)